Position in GILD
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$53,891,716
-$22,459,768 QoQ
Shares Held
426,561
-22.1% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#200
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Erste Asset Management GmbH holds $588,715,782 across 9 Drug Manufacturers - General names. GILD ranks #5 (9.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
130,143 | $156,097,431 | |
| 2 | JNJ |
Johnson & Johnson
|
519,951 | $132,051,955 | |
| 3 | MRK |
Merck & Co., Inc.
|
571,075 | $73,383,137 | |
| 4 | ABBV |
AbbVie Inc.
|
267,697 | $67,363,272 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
426,561 | $53,891,716 | |
| 6 | AMGN |
Amgen Inc
|
128,052 | $46,370,190 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
420,361 | $24,221,200 | |
| 8 | PFE |
Pfizer Inc
|
869,213 | $20,930,649 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,891,716 | 426,561 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $76,351,484 | 547,833 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $58,236,079 | 474,467 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $49,599,462 | 446,842 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $52,900,622 | 477,141 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $44,158,120 | 394,093 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $36,188,164 | 391,774 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $34,360,063 | 409,829 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $27,969,140 | 407,654 | Shares | Sole | 2024-11-26 | |
| 2024-03-31 | $29,656,654 | 404,869 | Shares | Sole | 2024-11-26 | |
| 2023-12-31 | $33,716,523 | 416,202 | Shares | Sole | 2024-11-26 | |
| 2023-09-30 | $29,223,077 | 389,953 | Shares | Sole | 2024-11-26 | |
| 2023-06-30 | $29,755,802 | 386,088 | Shares | Sole | 2024-11-26 | |
| 2023-03-31 | $38,961,882 | 469,590 | Shares | Sole | 2024-11-26 | |
| 2022-12-31 | $43,413,486 | 505,690 | Shares | Sole | 2024-11-26 | |
| 2022-09-30 | $27,249,213 | 441,712 | Shares | Sole | 2024-11-26 | |
| 2022-06-30 | $26,421,611 | 427,465 | Shares | Sole | 2024-11-26 | |
| 2022-03-31 | $24,674,544 | 415,047 | Shares | Sole | 2024-11-25 | |
| 2021-12-31 | $29,921,709 | 412,088 | Shares | Sole | 2024-11-25 | |
| 2021-09-30 | $26,747,241 | 382,924 | Shares | Sole | 2024-11-25 | |
| 2021-06-30 | $25,598,773 | 371,751 | Shares | Sole | 2024-11-25 | |
| 2021-03-31 | $24,379,082 | 377,210 | Shares | Sole | 2024-11-25 | |
| 2020-12-31 | $21,079,633 | 361,820 | Shares | Sole | 2024-11-25 | |
| 2020-09-30 | $22,202,438 | 351,360 | Shares | Sole | 2024-11-25 | |
| 2020-06-30 | $29,869,646 | 388,220 | Shares | Sole | 2024-11-22 | |
| 2020-03-31 | $23,489,965 | 314,205 | Shares | Sole | 2024-11-22 | |
| No filing history on record for this holder in this stock. | ||||||